A1.3 Humans In Space - Multi-planetary Life Enabler
Symposium: A1. IAF/IAA SPACE LIFE SCIENCES SYMPOSIUM
Session: 3. Medical Care for Humans in Space
Day: Tuesday 15.10.2024
Time: 15:00 CEST
Room: Yellow Hall 2
Humans In Space (HIS) is a global initiative led by Boryung to identify and solve Space Healthcare challenges by bringing together researchers, entrepreneurs, institutions, and corporations to address critical healthcare challenges for extended human presence in space and to improve healthcare on Earth through space-based innovations. This presentation aims to introduce the HIS Ecosystem and the benefits and opportunities it can provide to the Researchers attending the IAF/IAA Space Life Science Symposium, by highlighting ways to utilize HIS platform to facilitate not only on-ground, but also in-space research opportunities.
HIS categorizes space healthcare into two domains: 1) Critical Problems in Space and 2) Critical Problems on Earth. The first domain focuses on identifying and addressing health risks faced by astronauts, such as neurological, dermatological, respiratory, cardiovascular, immunological, renal, and musculoskeletal issues caused by prolonged microgravity or radiation exposure. The second domain explores how the space environment can be leveraged to address critical health challenges on Earth through research on molecular processes, radiation exposure, microbial systems, disease modeling, and manufacturing techniques like crystallization and tissue engineering. Each year, HIS identifies specific healthcare challenges with input from leading space agencies, including NASA HRP, ISSNL, and ESA.
Humans In Space Ecosystem presents a comprehensive value chain that strategically invests in and supports the development of space healthcare solutions, from the ideation process to actual implementation and commercialization. Through our annual Humans In Space Challenge, a global space healthcare challenge, Boryung invests in startups and researchers that develop critical technologies related to space healthcare. In our 1st and 2nd year, HIS has invested in 13 Startups, across different topics such as Bio R&D Platform, Human Health Journey and Molecular & Therapeutics and has awarded grants to five Researchers, focused in areas such as Cognitive, Immune, and Musculoskeletal problems related to space exploration. To name a few, HIS portfolio includes a Space Balance Impairment Treatment Company (Neursantys) and In-Space Artificial Retina Manufacturing Company (LambdaVision).
Through its investment, HIS aims to facilitate and enable on-orbit experiment of the Awardee’s research, and to circulate data and lesson-learned within its platform to foster greater collaboration in the Space Healthcare sector. HIS offers a Two Track Funding Model – the first track is our Equity Investment model and our second track is called the Orbital Launch Funding R&D Investment model that partially funds preparation and launch of research, through our extensive platform and implementation partners.